US Federal Register - DEA Telehealth Rules · December 31, 2025

Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications

DEA and HHS extend telemedicine flexibilities for controlled medication prescribing through December 31, 2026.

High impact Digital Health & AI Market Access & Reimbursement United States telehealthcybersecurity

The Drug Enforcement Administration (DEA) jointly with the Department of Health and Human Services (HHS) is issuing a fourth extension of telemedicine flexibilities for the prescribing of controlled medications through December 31, 2026.

Dates and deadlines

Applies from

2024-12-31

Regulatory Deadline

December 31, 2026

Read the official source ↗

Published by US Federal Register - DEA Telehealth Rules. HealthSignal links to the original document; the summary above is extracted from the source text.